Normal view MARC view ISBD view

Economic Impact of Mirabegron Versus Antimuscarinics for the Treatment of Overactive Bladder in the UK.

Nazir, Jameel

Economic Impact of Mirabegron Versus Antimuscarinics for the Treatment of Overactive Bladder in the UK. [electronic resource] - PharmacoEconomics - open Mar 2017 - 25-36 p. digital

Publication Type: Journal Article

ISSN: 2509-4254

Standard No.: 10.1007/s41669-017-0011-x doi

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)